Constitutive receptor systems for drug discovery

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• G-protein-coupled receptors (GPCRs) are crucial drug targets.
• Constitutive activity of GPCRs, or basal signaling without a ligand, is a known phenomenon.
• The ternary complex model provides a framework for understanding receptor-ligand interactions.

Purpose of the Study:

• To explore the utility of constitutively active GPCR systems in drug discovery.
• To evaluate the theoretical advantages of constitutive receptor screening.
• To experimentally validate the benefits of constitutive activity in receptor-ligand binding assays.

Main Methods:

• Utilized the ternary complex model to define theoretical advantages.
• Employed transient transfection of Chinese hamster ovary (CHO) cells with reporter genes (CRE luciferase).
• Expressed human parathyroid hormone (PTH-1), glucagon, glucagon-like peptide (GLP-1), and calcitonin receptors in cell systems.
• Assessed constitutive activity and ligand-induced responses in transfected cells and Xenopus laevis melanophores.

Main Results:

• Constitutive activity was observed for PTH-1 and glucagon receptors in CHO cells, dependent on cDNA concentration.
• GLP-1 receptor showed no constitutive activity, but responded to GLP-1, indicating successful expression.
• Human calcitonin receptor in Xenopus laevis melanophores exhibited constitutive activity, modulated by nine ligands.
• System sensitivity to human calcitonin increased with higher constitutive activity.

Conclusions:

• Constitutively active GPCR systems can be advantageous for drug discovery screening.
• These systems allow direct detection of both antagonists and agonists.
• Enhanced sensitivity to agonists is a key benefit of constitutive GPCR screening.
• The findings suggest that screening receptors with natural constitutive activity in this mode could outperform other methods.